Bluejay Diagnostics, Inc. Share-based Payment Arrangement, Expense
Bluejay Diagnostics, Inc. (BJDX) reported Share-based Payment Arrangement, Expense of $6 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-12
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $74.00.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $183.00, a 96.18% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was -$1.56K, a 126.01% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $1.31K, a 88.95% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2025 was $6.00, a 99.97% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2024 was $20.09K, a 89.38% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2023 was $189.25K, a 56.29% decline from fiscal 2022.
- Bluejay Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2022 was $433.00K, a 532.51% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $74.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $257.00 derived: sum of 2 quarters · filed 2026-03-06 | -$1.31K derived: sum of 3 quarters · filed 2026-08-12 | $6.00 10-K · filed 2026-03-06 | |||
| 2025-09-30 | $183.00 10-Q · filed 2025-11-07 | -$1.38K derived: sum of 2 quarters · filed 2026-08-12 | -$68.00 10-Q · filed 2025-11-07 | -$2.65K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$1.56K 10-Q · filed 2026-08-12 | -$251.00 10-Q · filed 2026-08-12 | -$2.83K derived: sum of 3 quarters · filed 2026-08-12 | $1.96K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $1.31K 10-Q · filed 2026-05-07 | -$1.27K derived: sum of 2 quarters · filed 2026-05-07 | $3.52K derived: sum of 3 quarters · filed 2026-05-07 | $9.53K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$2.58K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.21K derived: sum of 2 quarters · filed 2026-03-06 | $8.22K derived: sum of 3 quarters · filed 2026-03-06 | $20.09K 10-K · filed 2026-03-06 | |||
| 2024-09-30 | $4.79K 10-Q · filed 2025-11-07 | $10.80K derived: sum of 2 quarters · filed 2025-11-07 | $22.68K 10-Q · filed 2025-11-07 | $7.11K derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $6.01K 10-Q · filed 2025-08-07 | $17.88K 10-Q · filed 2025-08-07 | $2.32K derived: sum of 3 quarters · filed 2025-08-07 | -$40.16K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $11.87K 10-Q · filed 2025-05-13 | -$3.69K derived: sum of 2 quarters · filed 2025-05-13 | -$46.17K derived: sum of 3 quarters · filed 2025-05-13 | -$18.47K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$15.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$58.05K derived: sum of 2 quarters · filed 2025-03-31 | -$30.34K derived: sum of 3 quarters · filed 2025-03-31 | $189.25K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$42.48K 10-Q · filed 2024-11-07 | -$14.78K derived: sum of 2 quarters · filed 2024-11-07 | $204.81K 10-Q · filed 2024-11-07 | $292.39K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $27.70K 10-Q · filed 2024-08-14 | $27.70K 10-Q · filed 2023-08-14 | $247.29K 10-Q · filed 2024-08-14 | $247.29K 10-Q · filed 2023-08-14 | $334.88K derived: sum of 3 quarters · filed 2024-08-14 | $448.10K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $219.59K 10-Q · filed 2024-05-15 | $307.18K derived: sum of 2 quarters · filed 2024-05-15 | $420.39K derived: sum of 3 quarters · filed 2024-05-15 | $526.51K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2023-02-28 | $164.86K 10-Q · filed 2023-11-09 | ||||||
| 2022-12-31 | $87.59K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $200.81K derived: sum of 2 quarters · filed 2024-03-28 | $306.92K derived: sum of 3 quarters · filed 2024-03-28 | $433.00K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $113.22K 10-Q · filed 2023-11-09 | $219.33K derived: sum of 2 quarters · filed 2023-11-09 | $345.42K 10-Q · filed 2023-11-09 | $367.05K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $106.11K 10-Q · filed 2023-08-14 | $232.20K 10-Q · filed 2023-08-14 | $253.83K derived: sum of 3 quarters · filed 2023-08-14 | $300.34K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $126.09K 10-Q · filed 2022-05-09 | $147.72K derived: sum of 2 quarters · filed 2023-03-20 | $194.22K derived: sum of 3 quarters · filed 2023-03-20 | $194.38K derived: sum of 4 quarters · filed 2023-03-20 | |||
| 2021-12-31 | $21.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $68.14K derived: sum of 2 quarters · filed 2023-03-20 | $68.29K derived: sum of 3 quarters · filed 2023-03-20 | $68.46K 10-K · filed 2023-03-20 | |||
| 2021-09-30 | $46.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $46.66K derived: sum of 2 quarters · filed 2022-11-09 | $46.82K 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $155.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $319.00 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | $164.00 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | $7.37K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |